The Global Patient Engagement Solutions Market size is expected to reach $32.2 billion by 2023, rising at a market growth of 20.1% CAGR during the forecast period.
Patient engagement enables healthcare institutions to communicate with patients using online patient portal. Patient engagement is not only about engaging technology, it is a process that ensures patient satisfaction. Technology helps in improving service quality and ensures safety.
Growing medical tourism sector, growing adoption of cloud-based networking models and growing investments into the healthcare IT sector in the developing nations are the factors that is expected to propel the industry growth during the forecast period.
Scope of the Report
Based on component the market is segmented into Hardware, Software, and Service.
Based on Delivery Model, the market is categorised into On-Premise, Web based, and Cloud based.
Therapeutics segment includes chronic diseases, Fitness, Women's Health, Mental Health, and Others.
Based on end user, the market is segmented into Payers, Providers, and Individual Users.
Based on application, the market is segmented into Social Management, Health Management, Home Healthcare Management, and Financial Health Management.
Key companies profiled in the report include
Mckesson Corporation
IBM Corporation
Allscripts
Athenahealth, Inc.
Orion Health
Cerner
GetWellNetwork, Inc.
Lincor Solutions
Get Real Health
Oneview Healthcare
Key Topics Covered:
1. Market Scope & Methodology
2. Market Overview
3. Global Patient Engagement Solutions Market
4. Global Patient Engagement Solutions Market by Delivery Model
5. Global Patient Engagement Solutions Market by Application
6. Global Patient Engagement Solutions Market by End user
7. Global Patient Engagement Solutions Market by Therapeutics
8. Global Patient Engagement Solutions Market by Region
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...